CORCEPT THERAPEUTICS INC
Industry: Life Sciences ・ $CORT on Nasdaq
Insider Sale
+$357,390
-17.45%
Shares
Shares Volume: 11,000 Shares
Average Share Price: $32.49
INSIDER
Robb Gary Charles
Chief Business Officer (Officer)
reported on Jul 3 2024
traded on Jul 1 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 52,041 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $264,414.38 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 0 / 43 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $287,529.28 |
| COMPANY PREVIOUS TRADES |